General discussion, page-5141

Not sure I 100% agree, but get your thinking. Key for me is not EUA, it's what the FDA provide as feedback. Specifically of interest for me is if there is any leniency on trial procedures due to HCQ / CBD having known safety profiles. If we are allowed an easier route through in-human trials because of this then I think it'll be a big deal regardless of if EUA is granted. If it's both (EUA granted as well), then cue rockets / lambos / doge memes.

Still IMO the most important next announcement I have been hoping for (and still am) is the OSA trial update. Been a long time to get this up and at em, so hopefully not too long also!